Nobel Biocare erwirbt Matricel
Nobel Biocare Management AG
Pharma, Medizin & Biotec
Transfer Partners exclusively advised the shareholder of Matricel GmbH headquartered in Herzogenrath (Germany) on the sale of his shares to Nobel Biocare, a part of Envista Holdings (NYSE: NVST) headquartered in Brea, California (USA).
Matricel is a technological leader and manufacturer of medical class III collagen implants and matrices in the field of regenerative medicine. While many products are focused on dental applications, Matricel also develops solutions for orthopedics, nerve regeneration and other medical fields.
Headquartered in Switzerland, Nobel Biocare is a leading provider of products and technologies for dental applications such as implants, crowns, veneers, and dental bridges. The acquisition of Matricel aims at accelerating innovation and developments for dental applications.
As the exclusive advisor to the shareholder, Transfer Partners prepared all relevant transaction documents, managed the due diligence process and supported the shareholder during the final contract negotiations until the successful completion of the transaction.
Auch für Sie interessant: